August 26, 2015
Providence Medical Technology, Inc. today announced the full commercial launch of DTRAX Bone Screws in the U.S. market.
August 26, 2015
Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of $12 million in new financing for the company. The proceeds will be used to further commercialize and expand its portfolio of DTRAX® cervical fusion products designed to help patients suffering from cervical degenerative disc disease.
February 25, 2015
Providence Medical Technology, Inc. announced today it has obtained a CE Mark for its DTRAX Spinal System, DTRAX Cervical Cage, and DTRAX Bone Screw. This regulatory approval expands the company’s international product offering to include its entire DTRAX portfolio.
September 29, 2014
Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014.
July 1, 2014
Providence Medical Technology, Inc. announced today it has closed a $3 million venture debt agreement with East West Bank. The debt facility complements the $6.8 million venture funding that closed earlier in 2014.
March 31, 2014
Providence Medical Technology, Inc. today announced that it has closed a $6.8 million Series C round of financing. Stanmore Medical Investments led the round through its MedVest Fund One, and was joined by Aphelion Capital and RCT Ventures.
October 21, 2013
Providence Medical Technology, Inc. (PMT) today announced that two‐year follow‐up data on patients treated with the DTRAX Facet System will be available in the electronic poster session at the Congress of Neurological Surgeons (CNS) Annual Meeting in San Francisco, October 19‐23. This data represents follow‐up to the one‐year results published earlier in 2013 in the Journal of Neurosurgery: Spine.
January 13, 2013
Providence Medical Technology, Inc. (PMT) today announced that five U.S. patents have been issued in the past 12 months protecting the DTRAX® family of technologies, bringing the total number of U.S. patents issued to the company by the U.S. Patent Office to seven.
